When we do, it will be within a supervised clinical framework
Preclinical models have examined BPC-157s effects on blood vessel recruitment and fibroblast density in connective tissue, with repair outcome observations reported across ligament, tendon, and soft tissue models
Because muscles have a rich blood supply, this approach allows for rapid absorption, providing faster therapeutic effects than other delivery methods
Content Author & Reviewer PRP London Clinic Medical Team GMC-Registered Medical Professionals Our team of GMC-registered medical professionals collaboratively review all medical content to ensure clinical accuracy and provide evidence-based information for patient education
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a stable fragment of a naturally occurring protein
iCSF can be harvested at multiple timepoints to track changes of the presence and levels of proteins and inflammatory cytokines found within the iCSF, providing insight to the progression of disease